Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...

Niagara Falls, NY, June 14, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed ...

LUFKIN, Texas (KTRE) - Advanced Cardiology and Electrophysiology in Lufkin is now the first clinic in East Texas to offer cardiac PET/CT scanning - a technology that uses Positron Emission Tomography ...

Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners ...

The study by Choi et al 6 is of interest for a variety of reasons. Their radiomics model was able to predict clinical interpretation of cardiac FDG uptake patterns with good predictive accuracy. In ...

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...

Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.

DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

Access to cardiac positron emission tomography (PET) varies widely across the United States, with large swaths of the Midwest having few and in some cases no centers within a reasonable radius that ...

Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT ...

YARDLEY, Pa.--(BUSINESS WIRE)--Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities ...